IMP4 as A Potential Drug Target and Biomarker (G92856)

Target Name: IMP4

NCBI ID: G92856

IMP4

IMP4 as A Potential Drug Target and Biomarker

IMP4 (Immunomodulatory protein 4) is a protein that is expressed in various tissues of the human body. It plays a crucial role in the immune system, and its function is being investigated as a potential drug target or biomarker. IMP4 is a protein that can interact with various signaling pathways, including the PI3K/Akt signaling pathway. This signaling pathway is involved in various cellular processes, including cell survival, angiogenesis, and inflammation. As such, IMP4 has been shown to be a potential drug target or biomarker for various diseases, including cancer, autoimmune diseases, and neurodegenerative diseases.

The PI3K/Akt signaling pathway is a signaling pathway that is involved in the regulation of various cellular processes, including cell survival, angiogenesis, and inflammation. This pathway is composed of two main components: the protein kinase B (PKB) and the protein kinase Akt (PKA). PKB is a G protein-coupled receptor that is involved in the regulation of various cellular processes, including cell survival and angiogenesis. PKA is a regulatory protein that is involved in the regulation of various cellular processes, including cell survival, angiogenesis, and inflammation.

IMP4 is a protein that can interact with the PI3K/Akt signaling pathway. This interaction between IMP4 and the PI3K/Akt pathway has been shown to play a crucial regulatory role in the various cellular processes, including cell survival, angiogenesis, and inflammation. For example, studies have shown that IMP4 can interact with the PKB component of the PI3K/Akt pathway to regulate the activity of various cellular processes, including cell survival and angiogenesis.

In addition to its interaction with the PI3K/Akt pathway, IMP4 has also been shown to play a role in the regulation of inflammation. This is because IMP4 has been shown to interact with various signaling pathways that are involved in inflammation, including the NF-kappa-B signaling pathway. This signaling pathway is involved in the regulation of various cellular processes, including inflammation, cell survival, and angiogenesis.

IMP4 as a potential drug target

IMP4 has been shown to be a potential drug target for various diseases, including cancer, autoimmune diseases, and neurodegenerative diseases. This is because of its interaction with the PI3K/Akt signaling pathway, as well as its role in the regulation of various cellular processes , including cell survival, angiogenesis, and inflammation.

IMP4 has been shown to be involved in the regulation of cancer cell survival. For example, studies have shown that IMP4 can interact with the PI3K/Akt pathway to regulate the activity of various cellular processes, including cell survival and angiogenesis. This interaction between IMP4 and the PI3K/Akt pathway has been shown to play a role in the regulation of cancer cell survival.

IMP4 has also been shown to be involved in the regulation of autoimmune diseases. For example, studies have shown that IMP4 can interact with the PI3K/Akt pathway to regulate the activity of various cellular processes, including cell survival and angiogenesis. This interaction between IMP4 and the PI3K/Akt pathway has been shown to play a role in the regulation of autoimmune diseases.

IMP4 has also been shown to be involved in the regulation of neurodegenerative diseases. For example, studies have shown that IMP4 can interact with the PI3K/Akt pathway to regulate the activity of various cellular processes, including cell survival and angiogenesis. This interaction between IMP4 and the PI3K/Akt pathway has been shown to play a role in the regulation of neurodegenerative diseases.

IMP4 as a potential biomarker

IMP4 has also been shown to be a potential biomarker for various diseases, including cancer, autoimmune diseases, and neurodegenerative diseases. This is because of its interaction with the PI3K/Akt signaling pathway, as well as its role in the regulation of various cellular processes , including cell survival, angiogenesis, and inflammation.

IMP4 can be used as a potential biomarker for cancer. For example, studies have shown that IMP4 can interact with

Protein Name: IMP U3 Small Nucleolar Ribonucleoprotein 4

Functions: Component of the 60-80S U3 small nucleolar ribonucleoprotein (U3 snoRNP). Required for the early cleavages during pre-18S ribosomal RNA processing (PubMed:12655004). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:34516797)

The "IMP4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IMP4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets